These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35810714)

  • 1. Synthesis and mammalian cell compatibility of light-released glycan precursors for controlled metabolic engineering.
    Kondor CA; Gorantla JN; Leonard GD; Fehl C
    Bioorg Med Chem; 2022 Sep; 70():116918. PubMed ID: 35810714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of the performance of secretome analysis based on metabolic labeling by three unnatural sugars].
    Mao Y; Zheng J; Feng S; Tian R
    Se Pu; 2021 Oct; 39(10):1086-1093. PubMed ID: 34505430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialic acid glycoengineering using N-acetylmannosamine and sialic acid analogs.
    Moons SJ; Adema GJ; Derks MT; Boltje TJ; Büll C
    Glycobiology; 2019 Jun; 29(6):433-445. PubMed ID: 30913290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of vertebrate amino sugars with N-glycolyl groups: incorporation of N-glycolylhexosamines into mammalian glycans by feeding N-glycolylgalactosamine.
    Bergfeld AK; Pearce OM; Diaz SL; Lawrence R; Vocadlo DJ; Choudhury B; Esko JD; Varki A
    J Biol Chem; 2012 Aug; 287(34):28898-916. PubMed ID: 22692203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical reporters to study mammalian O-glycosylation.
    Huxley KE; Willems LI
    Biochem Soc Trans; 2021 Apr; 49(2):903-913. PubMed ID: 33860782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic glycoengineering: sialic acid and beyond.
    Du J; Meledeo MA; Wang Z; Khanna HS; Paruchuri VD; Yarema KJ
    Glycobiology; 2009 Dec; 19(12):1382-401. PubMed ID: 19675091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering sialic acid synthetic ability into insect cells: identifying metabolic bottlenecks and devising strategies to overcome them.
    Viswanathan K; Lawrence S; Hinderlich S; Yarema KJ; Lee YC; Betenbaugh MJ
    Biochemistry; 2003 Dec; 42(51):15215-25. PubMed ID: 14690432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialic acid O-acetylation: From biosynthesis to roles in health and disease.
    Visser EA; Moons SJ; Timmermans SBPE; de Jong H; Boltje TJ; Büll C
    J Biol Chem; 2021 Aug; 297(2):100906. PubMed ID: 34157283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass isotopomer analysis of metabolically labeled nucleotide sugars and N- and O-glycans for tracing nucleotide sugar metabolisms.
    Nakajima K; Ito E; Ohtsubo K; Shirato K; Takamiya R; Kitazume S; Angata T; Taniguchi N
    Mol Cell Proteomics; 2013 Sep; 12(9):2468-80. PubMed ID: 23720760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: increase in O-glycan core 2 UDP-GlcNAc:Gal beta 3 GalNAc alpha-R (GlcNAc to GalNAc) beta(1-6)-N-acetylglucosaminyltransferase in leukemic cells.
    Brockhausen I; Kuhns W; Schachter H; Matta KL; Sutherland DR; Baker MA
    Cancer Res; 1991 Feb; 51(4):1257-63. PubMed ID: 1997166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human UDP-galactose 4'-epimerase (GALE) is required for cell-surface glycome structure and function.
    Broussard A; Florwick A; Desbiens C; Nischan N; Robertson C; Guan Z; Kohler JJ; Wells L; Boyce M
    J Biol Chem; 2020 Jan; 295(5):1225-1239. PubMed ID: 31819007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modular pathway engineering of key carbon-precursor supply-pathways for improved N-acetylneuraminic acid production in Bacillus subtilis.
    Zhang X; Liu Y; Liu L; Wang M; Li J; Du G; Chen J
    Biotechnol Bioeng; 2018 Sep; 115(9):2217-2231. PubMed ID: 29896807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycosyltransferase changes upon differentiation of CaCo-2 human colonic adenocarcinoma cells.
    Brockhausen I; Romero PA; Herscovics A
    Cancer Res; 1991 Jun; 51(12):3136-42. PubMed ID: 1904002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biosynthesis of GlcNAc-rich
    Szulc B; Sosicka P; Maszczak-Seneczko D; Skurska E; Shauchuk A; Olczak T; Freeze HH; Olczak M
    J Biol Chem; 2020 Nov; 295(48):16445-16463. PubMed ID: 32938718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing O-glycan core 1, Gal beta 1-3GalNAc alpha-R. Specificities of core 2, UDP-GlcNAc: Gal beta 1-3 GalNAc-R(GlcNAc to GalNAc) beta 6-N-acetylglucosaminyltransferase and CMP-sialic acid: Gal beta 1-3GalNAc-R alpha 3-sialyltransferase.
    Kuhns W; Rutz V; Paulsen H; Matta KL; Baker MA; Barner M; Granovsky M; Brockhausen I
    Glycoconj J; 1993 Oct; 10(5):381-94. PubMed ID: 8298305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic defects in the hexosamine and sialic acid biosynthesis pathway.
    Willems AP; van Engelen BG; Lefeber DJ
    Biochim Biophys Acta; 2016 Aug; 1860(8):1640-54. PubMed ID: 26721333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic oligosaccharide engineering: perspectives, applications, and future directions.
    Campbell CT; Sampathkumar SG; Yarema KJ
    Mol Biosyst; 2007 Mar; 3(3):187-94. PubMed ID: 17308665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic engineering challenges of extending N-glycan pathways in Chinese hamster ovary cells.
    Wang Q; Wang T; Yang S; Sha S; Wu WW; Chen Y; Paul JT; Shen RF; Cipollo JF; Betenbaugh MJ
    Metab Eng; 2020 Sep; 61():301-314. PubMed ID: 32663509
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.